Carbenoxolone sodium.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004381:Duodenal Ulcer / Q000188:drug therapy; D004386:Duodenum / Q000187:drug effects; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects; D005750:Gastric Juice / Q000187:drug effects; D005752:Gastric Mucins / Q000096:biosynthesis / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects; D006035:Glycyrrhiza; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D008938:Mitosis / Q000187:drug effects; D009212:Myoglobinuria / Q000139:chemically induced; D010434:Pepsin A / Q000037:antagonists & inhibitors; D010946:Plants, Medicinal; D011485:Protein Binding; D012964:Sodium / Q000378:metabolism; D013276:Stomach Ulcer / Q000188:drug therapy; D013729:Terpenes / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors
D005752:Gastric Mucins; D013729:Terpenes; D012964:Sodium; D013937:Thymidine Kinase; D010434:Pepsin A